Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP ‐1‐Based Therapy

医学 骨骼肌 减肥 瘦体质量 肌萎缩 内分泌学 脂肪组织 内科学 合成代谢 不利影响 胰岛素抵抗 生物信息学 2型糖尿病 糖尿病 肥胖 代谢综合征 动物研究 胰岛素 葡萄糖摄取 炎症 受体 结缔组织
作者
Esma Sukurica,Goksemin Fatma Sengul,Fatma Uysal
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
被引量:1
标识
DOI:10.1111/dom.71422
摘要

Glucagon-like peptide-1 receptor agonists and newer dual- and triple-incretin receptor agonists have transformed obesity treatment by producing substantial and sustained weight loss. However, reported reductions in lean body mass have raised concerns about potential skeletal muscle loss and sarcopenia, particularly in older adults and individuals with limited muscle reserves. This review examines the cellular and tissue-level mechanisms that may contribute to lean mass changes during GLP-1-based therapy and evaluates strategies for preserving skeletal muscle. Reductions in fat-free or lean body mass should not be interpreted as equivalent to loss of contractile skeletal muscle, as these compartments also include body water, organs, connective tissue, and the fat-free component of adipose tissue. Incretin-based therapies predominantly reduce fat mass, while preclinical studies and limited human evidence suggest possible improvements in skeletal muscle quality through enhanced insulin sensitivity, reduced myosteatosis and inflammation, and favourable mitochondrial adaptations. Nevertheless, the proportion of lean mass reduction attributable to true skeletal muscle loss and its long-term functional significance remain uncertain. Rapid weight loss and inadequate nutrient intake may increase the risk of clinically relevant muscle loss in susceptible populations. Individualized protein intake, progressive resistance exercise, management of gastrointestinal adverse effects, and functional monitoring therefore represent the reasonable strategies for skeletal muscle preservation. Emerging anabolic combination therapies remain investigational and should be evaluated using strength and physical performance outcomes in addition to body composition. Accordingly, this review explores the potential mechanisms underlying skeletal muscle changes during GLP-1-based therapy and discusses strategies to support muscle preservation during therapy-induced weight loss. Ultimately, the success of GLP-1-based therapy should be defined not only by the magnitude of weight loss, but also by the extent of that weight loss and the preservation of skeletal muscle mass and function.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
NoMigraine发布了新的文献求助10
刚刚
1秒前
小玉完成签到,获得积分10
1秒前
柚子关注了科研通微信公众号
1秒前
结痂的小石头完成签到 ,获得积分10
1秒前
儒雅沛蓝发布了新的文献求助10
1秒前
杨胖胖完成签到,获得积分10
1秒前
俭朴兔子完成签到,获得积分10
1秒前
guohh完成签到,获得积分10
1秒前
佳宜发布了新的文献求助10
1秒前
Lin完成签到,获得积分10
1秒前
阿梨完成签到,获得积分10
1秒前
1秒前
思念变成王年年完成签到,获得积分10
1秒前
1秒前
尹依依完成签到 ,获得积分10
2秒前
didi发布了新的文献求助10
2秒前
2秒前
在水一方的应助被徐小新采纳,获得10
2秒前
Lucas的应助被Arthur采纳,获得10
2秒前
李建国发布了新的文献求助10
3秒前
3秒前
3秒前
cdercder的应助被白英采纳,获得10
3秒前
暖羊羊Y发布了新的文献求助10
3秒前
小杰发布了新的文献求助10
4秒前
4秒前
水长东完成签到,获得积分10
4秒前
梦幻之星完成签到,获得积分10
4秒前
北执完成签到,获得积分10
4秒前
5秒前
句号博发布了新的文献求助10
5秒前
zzz完成签到,获得积分10
6秒前
6秒前
6秒前
6秒前
6秒前
honda完成签到,获得积分10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153442
求助须知:如何正确求助?哪些是违规求助? 9550127
关于积分的说明 21696715
捐赠科研通 7741908
什么是DOI,文献DOI怎么找? 3425483
关于科研通互助平台的介绍 2550608
邀请新用户注册赠送积分活动 2469152